0 items USD 0.00Search
Your search for "Silicon Controlled Rectifier (SCR)" gave back 23 results.
Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
bioMerieux SA. - Strategy, SWOT and Corporate Finance Report Summary bioMerieux SA. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
Getinge AB - Strategy, SWOT and Corporate Finance Report Summary Getinge AB - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
December 2022
Price: USD 175.00
Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and...
MarketLine
October 2022
Price: USD 175.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Dr. Reddy鈥檚 Laboratories is an India based multinational...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023. Astellas Pharma Inc. is a Japanese...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
听
